argenx SE - Special Call Company Participants Beth DelGiacco - VP and Global Head of Corporate Communications & Investor Relations Roeland Vanhauwaert Peter Ulrichts - Chief Scientific Officer Luc Truyen - Chief Medical Officer Rebecca Shilling Jeff Guptill Tim Van Hauwermeiren - Co-Founder, CEO & Executive Director Conference Call Participants Steven Burden Ricardo Maselli Danielle Brill Bongero - Truist Securities, Inc., Research Division Yaron Werber - TD Cowen, Research Division Ricardo Maselli, M.D. Leland Gershell - Oppenheimer & Co. Inc., Research Division Tazeen Ahmad - BofA Securities, Research Division Patrick Culliton - Stifel, Nicolaus & Company, Incorporated, Research Division Maddalena Delma Caiati - Guggenheim Securities, LLC, Research Division Presentation Beth DelGiacco VP and Global Head of Corporate Communications & Investor Relations Good afternoon.
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Curtis Ralph William Huber CEO | OTC PINK Exchange | CA37953Y2033 ISIN |
| CA Country | - Employees | - Last Dividend | 28 Sep 2023 Last Split | - IPO Date |
Global Hemp Group Inc. is a company engaged in the production and processing of industrial hemp in the United States, focusing on the creation of green and sustainable value-added hemp products. The company leverages the versatile applications of the hemp plant to develop products that contribute to environmental sustainability. Originally known as Arris Holdings Inc., it underwent a name change to Global Hemp Group Inc. in March 2014, signaling a more focused shift towards the hemp industry. Established in 2009 and based in North Vancouver, Canada, Global Hemp Group Inc. is at the forefront of harnessing the economic and eco-friendly potential of industrial hemp.
Global Hemp Group Inc. delivers a wide range of products and services centered around the industrial processing of hemp for various markets. The company's offerings include: